Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

53.1K
Overview
53.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The C-terminal region of <i>Opisthorchis viverrini</i> granulin-1 promotes cell proliferation in the absence of regular secondary structure.

Australian journal of chemistry·2026
Same author

Transcriptional profiling of the Crocodylus porosus liver cell response to Kunjin virus reveal novel insights into the host-virus interface.

Microbial pathogenesis·2026
Same author

A novel hookworm vaccine candidate identified through immunomic profiling of human protective immunity.

International journal for parasitology·2026
Same author

Transgenic hookworm secretes anti-tetrodotoxin human single chain antibody.

Nature communications·2026
Same author

Advances in vaccine development through the controlled human infection models for hookworm and schistosomiasis.

PLoS neglected tropical diseases·2026
Same author

Optimized hookworm-derived biologic, AIP-2<sub>NTQ48</sub> restores mucosal tolerance and down-regulates colon cancer-associated gene expression in TNBS-induced colitis.

Mucosal immunology·2026

Related Experiment Video

Updated: Mar 14, 2026

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

12.5K

Schistosomiasis vaccines: where do we stand?

Biniam Mathewos Tebeje1,2,3, Marina Harvie4, Hong You4

  • 1QIMR Berghofer Medical Research Institute, Brisbane, Australia. Biniam.Tebeje@qimrberghofer.edu.au.

Parasites & Vectors
|October 8, 2016
PubMed
Summary

Schistosomiasis remains a major public health issue. Developing anti-schistosome vaccines is crucial for prevention and control, as current drugs like praziquantel have limitations.

Keywords:
Antigen discoveryImmune protectionImmune responseSchistosoma haematobiumSchistosoma japonicumSchistosoma mansoniSchistosomiasisVaccine

More Related Videos

Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni
12:05

Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni

Published on: January 14, 2018

9.9K
Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules
05:30

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules

Published on: August 16, 2011

18.8K

Related Experiment Videos

Last Updated: Mar 14, 2026

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

12.5K
Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni
12:05

Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni

Published on: January 14, 2018

9.9K
Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules
05:30

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules

Published on: August 16, 2011

18.8K

Area of Science:

  • Tropical medicine
  • Parasitology
  • Vaccinology

Background:

  • Schistosomiasis is a debilitating tropical disease caused by parasitic flatworms (Schistosoma species).
  • Current treatment relies on praziquantel, which has limitations including inability to target developing parasites and potential for drug resistance.
  • High morbidity rates persist in endemic regions, necessitating novel control strategies.

Purpose of the Study:

  • To review the current status of candidate anti-schistosome vaccines.
  • To discuss future directions in vaccine discovery and design for schistosomiasis.

Main Methods:

  • Literature review of existing research on schistosomiasis vaccines.
  • Analysis of praziquantel's limitations and the need for alternative interventions.

Main Results:

  • Several candidate vaccines are under development for schistosomiasis.
  • Vaccine development is essential to complement praziquantel and combat drug resistance.

Conclusions:

  • Anti-schistosome vaccines are vital for integrated schistosomiasis control and elimination efforts.
  • Further research into vaccine discovery and design is needed to overcome current challenges.